Publications

October 22, 2026

Outcomes of patients with metastatic urothelial carcinoma following prior enfortumab vedotin-pembrolizumab: A real-world analysis

Bladder cancer

Authors: Guru P. Sonpavde, Jennifer R. Rider, Medhavi Kumari, Shaalan Beg

Read publication

October 16, 2026

Real-world treatment patterns, outcomes, and burden of early progression in small cell lung cancer (SCLC) in the US.

Lung cancer

Authors: Su Zhang, Franziska Dirnberger, Sunny Ubi, Jessie Wang, Xerxes Pundole, Catherine Chan, Diana Younan, Hongbo Yang, Shumin Rui, Tianxiu Li

Read publication

October 12, 2026

Impact of social determinants of health on genomic testing among patients with advanced/metastatic non-small cell lung cancer.

Lung cancer

Authors: Eileen Milien, Pritha Ghosh, Shaalan Beg, and Jennifer Rider

Read publication

September 28, 2026

Validation of interstitial lung disease diagnosis codes in electronic health records and integrated open claims among cancer patients in the United States

Lung cancer

Authors: Doherty, B. T., Thai, N. H., Wang, Y., Kariburyo-Yay, F., Karpes Matusevich, A. R., Yu, R., Ren, J., & Ghazarian, A. A.

Read publication

August 30, 2026

Validation of an all-source composite mortality endpoint in the US population

N/A

Authors: Yanina Natanzon, Lukas Slipski & Mark S Walker

Read publication

August 28, 2026

Epidemiology of folate receptor alpha expression in ovarian cancer by age, race/ethnicity, and histotype in a real-world, US-based clinicogenomic database

Ovarian Cancer

Authors: Rebecca C. Arend, MD, MSPH - University of Alabama at Birmingham, Birmingham, Alabama, USA; Kent F. Hoskins, MD - University of Illinois Chicago, ...

Read publication

May 31, 2026

Survival outcomes of cabazitaxel or subsequent androgen receptor pathway inhibitor (ARPI) in post-docetaxel/ARPI metastatic castration-resistant prostate cancer

Prostate cancer

Authors: Barata PC, Green L, Kim C, Hwang Y

Read publication

May 28, 2026

AI-enabled clinical trial framework for end-to-end site recommendation and enrollment projection

N/A

Authors: Yip SS, Ruchlin I, Chawla J, Patel P, Auth K, Prior K, Zambon B, Dupont F, Tibbs C, Gurha P

Read publication

May 28, 2026

Real-world treatment patterns and clinical outcomes among cholangiocarcinoma patients treated with futibatinib or pemigatinib

Cholangiocarcinoma

Authors: Mahipal A, Christensen D, Penney K, Tepsick JG, Lan Z, Zhao R

Read publication

May 28, 2026

Real-world effectiveness of MET inhibitors versus immunotherapy ± chemotherapy in 1L for patients with MET exon 14 skipping mutations in non-small cell lung cancer

Lung cancer

Authors: Pradhan P, George R, Saini KS, J S, Veinalde R, Berraondo MI, Nunes Filho PRS, Dutra C, Batra U, Pecci F, Ricciuti B, Rider J, Cantini L

Read publication

May 28, 2026

Biomarker-defined outcomes in metastatic clear cell renal cell carcinoma (mccRCC) receiving first-line (1L) immune checkpoint inhibitor-based therapy

Renal cell carcinoma

Authors: Shah KU, Rider J, Pindale R, Zugman M, Jaime-Casas S, Abreu De Goes V, Moradi A, Salgia N, Zang PD, Castro DV, Mercier B, Zhang G, Li Y, Dizman N, ...

Read publication

May 28, 2026

Association of mRNA COVID-19 vaccination near immune checkpoint inhibitor initiation with outcomes: A real-world analysis

Multiple tumor types

Authors: Jiang C, Rider J, Kontoyiannis PD, Pandiri VK, Sadeghi N, Beg S

Read publication

May 28, 2026

National perspectives on artificial intelligence use in cancer care: Confidence, adoption, and barriers

N/A

Authors: van Oort T, Colwell NA, Flora DB, Dicker AP, Fortune E, Bires J, Penberthy DR, Patt DA, Ajayi O, Chung C, Beg S, Parwani AV, Plotkin E

Read publication

May 28, 2026

Contemporary real-world patterns of precision medicine in metastatic NSCLC

Lung cancer

Authors: Gor J, Singh S, Aseem A, Kataria S, Naffakh N, Nguyen RH

Read publication

May 28, 2026

Developing a pan-cancer foundation model for digital patient representation and clinical prediction across real-world oncology data

Multiple tumor types

Authors: Parmar D, Ruchlin I, Thummagunti S, Gurha P, Yip SS

Read publication

May 28, 2026

A multi-agent AI system integrating real-world data and competitive intelligence to generate automated trial eligibility recommendations

N/A

Authors: Yip SS, Thummagunti S, Auth K, Patel P, Prior K, Zambon B, Dupont F, Tibbs C, Chawla J, Gurha P

Read publication

May 28, 2026

Systemic anticancer therapy in patients with de novo metastatic pancreatic adenocarcinoma: A real-world analysis

Pancreatic cancer

Authors: Bajaj P, Pradhan P, Wang Y, Karpes-Matusevich AR, Lan Z, Kent B, Gustafson WC, Graham J

Read publication

May 28, 2026

Clinical outcomes among patients with metastatic non-small cell lung cancer (mNSCLC) who received immune checkpoint inhibitors (ICI) in first (1L) and second line (2L)

Lung cancer

Authors: Wonsettler T, Fridman A, Karpes-Matusevich AR, Penney K, Hertler AA

Read publication

May 28, 2026

Artificial intelligence–enabled analysis of unstructured EHR data for identification of actionable HER2-low breast cancer phenotypes

Breast cancer

Authors: Patel A, Williford A, Ephraim A, Soto Pérez de Celis E, Hafez M, Brown TJ, Keswarpu P, Chandwani S, Rider J, Gurha P, Beg S, Joseph-Thomas J

Read publication

May 28, 2026

Real-world trends in the evolving use of first-line therapy in metastatic castration-sensitive prostate cancer patients (mCSPC) in the United States.

Prostate cancer

Authors: Aragon-Ching JB, Pierattini C, Karovic S, Dvergsten E

Read publication

May 28, 2026

PSA nadir–stratified outcomes of ARPI doublet and docetaxel triplet therapy in metastatic prostate cancer

Prostate cancer

Authors: Zugman M, Rider J, Pindale R, Shah KU, Moradi A, Jaime-Casas S, Zang PD, Salgia N, Abreu De Goes V, Sahu D, Ebrahimi H, Barragan-Carrillo R, Dizman ...

Read publication

May 28, 2026

A US-based, retrospective, observational study of biomarker testing patterns across lines of therapy in patients with metastatic colorectal cancer

Colorectal cancer

Authors: Kolhe R, Mukherjee V, Ng S, Beruti S, Quadri S, Liu K, Zagadailov E, Kamalakar R, Werner M, Sepulveda A

Read publication

May 14, 2026

Clinical and molecular predictors of response to Lu-177-PSMA-617 in metastatic castration-resistant prostate cancer

Prostate cancer

Authors: Pe Benito RA, Mohammed SKM, Nathasingh B, Jairam S, Gordon S, Kong E, Chandwani S

Read publication

April 16, 2026

Prevalence and distinct biological programs of small cell lung cancer molecular subtypes revealed by real-world clinico-genomics database

Lung cancer

Authors: Luo Y, Wang L, Jahchan N, Ansell P, Zhao X, Zhao W

Read publication

April 16, 2026

Epidemiology of folate receptor alpha expression in ovarian cancer by age, race/ethnicity, and histotype in a real-world, US-based clinicogenomic database

Ovarian cancer

Authors: Arend RC, Hoskins KF, Guadamuz JS, Calip GS, Clarke MA, Choi YC, Zhang Q, Lastra RR, Strickland AL, Lynam SK

Read publication

April 16, 2026

Multi-modal real-world data uncovers predictors of clinical response to TOP1i and optimizes ADC strategies in colorectal cancer

Colorectal cancer

Authors: Tafazzol A, Cruz-González S, Shi X, Dezso Z, Kline DE, Chen J, Ansell PJ, Popovic R, Chen R, Samayoa J, Zhao X, Zhao W

Read publication

April 16, 2026

A deep learning-based multimodal integration framework for clinical outcome prediction

Lung cancer

Authors: Zhang B, Tian H, Bui T, Choi YC, Cai MH, Ansell P, Shrotre A, Chirieleison S, Kolahi K, Zhao X, Samayoa J, Zhao W

Read publication

March 8, 2026

Harmonizing logical observation identifiers names and codes (LOINC) codes and units in real-world oncology data: Method development and evaluation

N/A

Authors: Naliyatthaliyazchayil P, Stenerson T

Read publication

March 4, 2026

Real-world study characterizing patient characteristics, treatments, and unmet need in IO-ineligible patients with metastatic triple-negative breast cancer

Breast cancer

Authors: Nguyen M, Shah R, Leclair B, Kariburyo-Yay F, Matusevich A, Mandora P

Read publication

February 28, 2026

Real-world treatment patterns, recurrence, and overall survival of patients with muscle-invasive bladder cancer undergoing radical cystectomy in U.S. oncology practice

Bladder cancer

Authors: Squires P, Coutinho F, Tepsick JG, Rogiers A, Ramamurthy C, Li H, Morgan TM

Read publication

February 25, 2026

Clinical outcomes of patients with metastatic colorectal cancer treated with trifluridine-tipiracil + bevacizumab by performance status

Colorectal cancer

Authors: Nusrat M, Zhao R, He Y, Penney KL, Lan Z, Wang Y, Salimi T, Roby L, Andre T, Calleja E, Cann C

Read publication

February 25, 2026

Androgen-receptor pathway inhibitors triplet therapy (ARAAT): Real-world outcomes in metastatic hormone-sensitive prostate cancer

Prostate cancer

Authors: Morgans AK, Khan N, Ghadessi M, McKay R, Chen G, George DJ

Read publication

February 24, 2026

Real-world effectiveness of frontline treatments among patients with chronic lymphocytic leukemia: Results from ConcertAI

Chronic Lymphocytic Leukemia

Authors: Roeker LE, Burke JM, Rhodes JM, Emechebe N, Jawaid D, Manzoor BS, Jensen CE, Ryland L, Liu Y, Marx SE, Sinai W, Roser J, Shadman M

Read publication

February 23, 2026

Trifluridine–tipiracil with and without bevacizumab in colorectal cancer

Colorectal cancer

Authors: Nusrat M, Zhao R, Khan N, Wang Y, Penney KL, Cann CG, Salimi T

Read publication

February 16, 2026

Real-world study of use patterns and clinical outcomes for patients with myelodysplastic syndrome initiating oral decitabine and cedazuridine or intravenous/subcutaneous hypomethylating agents

Myelodysplastic syndrome

Authors: Zeidan A, Zhao R, Tepsick JG, Lan Z, Salimi T

Read publication

January 31, 2026

Biomarker testing and patterns of treatment in NSCLC patients: An IASLC analysis of ASCO CancerLinQ Discovery data

Lung cancer

Authors: Behera M, Joseph G, Rupji M, Huang Z, Bunn B, Wynes MW, Switchenko J, Scagliotti GV, Tsao MS, Belani CP, Sequist LV, Ramalingam SS

Read publication

January 26, 2026

Exploration of real-world outcomes in patients with previously treated HR+/HER2- and triple negative metastatic breast cancer

Breast cancer

Authors: Sadetsky N, Prince P, Latimer H, Advani P, Smith-Gaziani D, Kaufman PA, Natanzon Y, Taylor A, Nguyen L, Freemantle N

Read publication

January 22, 2026

Emulating comparative oncology trials with real-world evidence studies (ENCORE): Process development and methodological considerations for oncology real-world data

Multiple tumor types

Authors: Weberpals J, Schneeweiss S, Kehl KL, Rivera DR, Mishra-Kalyani P, Lerro CC, Larkins E, Narayan P, Curley R, Hahn G, Anand P, Natanzon Y, Belli AJ, ...

Read publication

January 20, 2026

Impact of real-world response to first-line immunotherapy and chemotherapy on subsequent treatment outcomes in patients with advanced or metastatic non-small cell lung cancer

Lung cancer

Authors: Malhotra J, Viswanathan S, Mhatre SK, Dhillon IK, Patel R, Yohn N, Kariburyo-Yay F, Li X, Ricciuti B

Read publication

January 19, 2026

Pathway-level molecular evolution and composite molecular genomic risk following Lu-177-PSMA-617 in metastatic castration-resistant prostate cancer

Prostate cancer

Authors: Pe Benito R, Mohammed SKM, Nathasingh B, Liao J, Khotskaya Y, Jairam S, Chandwani S

Read publication

January 19, 2026

Utilization of liquid biopsy in metastatic castrate resistant prostate cancer (mCRPC): patient characteristics, treatment selection, and mutational status

Prostate cancer

Authors: Hall MS, Penney KL, Liao J, Gordon S, Overstreet B, Rossi M, Rider JR

Read publication

January 7, 2026

Biomarker prevalence in US patients with gastric/gastroesophageal junction adenocarcinoma (GEA) from real-world data

Gastric cancer/Gastroesophageal junction cancer

Authors: Rudra-Ganguly N, Luo H, Zhao W, Ganesan S, Predoiu R, Leibman R, Walker G, Ansell P

Read publication

January 7, 2026

A multi-agent system for automated identification of competitive clinical trials in colorectal cancer

Colorectal cancer

Authors: Yip SSF, Chawla J, Rossi MR, Chandwani S, Gurha P

Read publication

January 7, 2026

Real-world clinical outcomes among metastatic colorectal cancer (mCRC) patients with liver metastases who received trifluridine/tipiracil (FTD/TPI) or FTD/TPI + bevacizumab (FTD/TPI+bev) combination therapy

Colorectal cancer

Authors: Kim RD, Christensen D, Penney KL, Khan N, Yeola S, Pandiri VK, Zhao R

Read publication

December 31, 2025

A United States-based real-world study on biomarker testing and rebiopsy rates among patients with non-small cell lung cancer across lines of therapy

Lung cancer

Authors: Aggarwal C, Ng S, Kamalakar R, Beruti S, Simmons A, Beasley MB

Read publication

December 5, 2025

Real-world characteristics, treatment modifications, and outcomes for patients with acute myeloid leukemia (AML) receiving hypomethylating agents (HMA) + venetoclax (VEN) as first-line treatment (1L)

Acute Myeloid Leukemia

Authors: Zeidan A, Wang Y, Yu R, Matusevich A, Zhao R

Read publication

December 5, 2025

Real-world monotherapy and combination usage of mogamulizumab among patients with mycosis fungoides or Sézary syndrome in the United States

Mycosis fungoides and Sezary syndrome

Authors: Haverkos B, Chang C, Ristuccia R, DeGutis I, Chang Y, Friderici J, Rozati S

Read publication

December 5, 2025

Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study

Lung cancer

Authors: Chouaid C, Bosquet L, Knott C, Li Z, Schaeffer M, Lin X, Schioppa CA, Perualila NJ, Diels J, Caparros EQ, Galea F, Hultén A, Greystoke A

Read publication

December 4, 2025

Real-world EGFR testing and adjuvant treatment patterns among patients with resected early-stage non-small cell lung cancer (NSCLC) in the United States

Lung cancer

Authors: Kariburyo-Yay F, Liang Y, Simmons D, Miller V, Pye J, Ursino G

Read publication

November 12, 2025

Shifting treatment patterns in chromophobe renal cell carcinoma: A U.S. real-world data analysis

Renal cell carcinoma

Authors: Zugman M, Rider JR, Dizman N, Jaime-Casas S, Castro DV, Mercier B, Salgia NJ, Shah K, Abreu de Góes V, Barragan-Carrillo R, Sahu D, Mandora PV, Hsu ...

Read publication

November 11, 2025

Using AI methodology to stack and harmonize two U.S. EMR databases

Breast cancer

Authors: Pierzynski J, Elashoff M, Lynn A, Mathur R, Chandwani S, Katz JA, Sadetsky N, McMahon P

Read publication

November 11, 2025

Leveraging NSCLC foundation models to predict biomarker testing pattern

Lung cancer

Authors: Yip SS, Parmar D, Ruchlin I, Thummagunti S, Chandwani S, Gurha P

Read publication

November 8, 2025

Correlation of intermediate clinical endpoints (ICES) for overall survival (OS) in localized or locally advanced prostate cancer (LPC/LAPC): Analysis of individual real-world data (RWD)

Prostate cancer

Authors: Jahn B, Krabbe LM, Merseburger AS, Shore ND, De Solda F, Nair S, Price M, Sacchi E, Schaeffer M, Tang A, McCallion J, Lin X, McCarthy SA, Mundle SD, ...

Read publication

November 8, 2025

Developing an EHR-based multifeature machine learning model to identify lung cancer subtype

Lung cancer

Authors: Chandwani S, Priya V, Vaidya VP

Read publication

November 5, 2025

Real-world treatment patterns among advanced non-small cell lung cancer patients in the US

Lung cancer

Authors: Chen Y, Carlson A, Schommer J, Stenehjem D, Zhang D

Read publication

October 16, 2025

Predicting real-world overall survival in advanced melanoma using machine learning

Melanoma

Authors: Wang F, Hathi D, Chi L, Wu N, Nkhoma E, Harnett J, Salvati ME, Lewis K, Li Y

Read publication

October 16, 2025

Seizure related 6 homolog (SEZ6) expression pattern and prognostic impact in a real-world cohort of patients with small cell lung cancer

Lung cancer

Authors: Chiang AC, Wang L, Xu D, Luo A, Ansell PJ, Wang S

Read publication

October 16, 2025

Real-world prostate-specific antigen (PSA) response with darolutamide or abiraterone in metastatic hormone-sensitive prostate cancer (mHSPC) triplet therapy

Prostate cancer

Authors: Morgans AK, McKay RR, Khan N, Ghadessi M, Chen G, George DJ

Read publication

October 16, 2025

Real-world characteristics and outcomes of patients with third-line or later metastatic colorectal cancer: Magnetic-101 study results

Colorectal cancer

Authors: Goetze TO, Xu Q, Ng S, Mudumba R, Kamalakar R, Quadri S, Desai K, Fang H, Patel M, Neagu Aristide MR, Jin Z

Read publication

October 5, 2025

Predictive modeling for survival outcomes in surgically resected pancreatic ductal adenocarcinoma: A comprehensive machine learning approach using real-world data

Pancreatic cancer

Authors: Ahmed KS, Issaka SM, Cher BAY, Marcinak CT, Zafar SN

Read publication

September 30, 2025

Real-world treatment patterns and survival in people with metastatic castration-resistant prostate cancer following metastatic hormone-sensitive disease between 2020 and 2023 in the United States

Prostate cancer

Authors: Raval AD, Chen G, Korn MJ, Bernthaler A, Constantinovici N, Freedland SJ

Read publication

September 22, 2025

Quantification of information gained by linking claims data to an electronic health record cohort of patients with metastatic breast cancer

Breast cancer

Authors: Geddes J, Katz J, Asiimwe A, Brookhart MA, Carroll C, Eldemir L, Mucaj V, Nolan K, Ntalla I, Nielson CM

Read publication

September 5, 2025

Computational modeling of comprehensive genomic profiling to predict chemotherapy benefit in advanced NSCLC

Lung cancer

Authors: Aggarwal C, Watson D, Nair P, Kumar A, Khandelwal S, Chauhan J, Khanna S, George S, Dey A, Patil M, Ganesh N, Purushottam R, Kulkarni S. G P, Lala ...

Read publication

September 5, 2025

Effect of IFNG expression levels on real-world survival outcomes in patients with metastatic non-small cell lung cancer receiving immunotherapy

Lung cancer

Authors: Altoe M, Papillon-Cavanagh S, Poi M, Yip S, Oakland T, Rossi MR

Read publication

August 21, 2025

Epidemiology of MET gene mRNA expression in metastatic colorectal cancer: Analyses of a real-world clinicogenomic database

Colorectal cancer

Authors: Calip GS, Choi YC, Cai MH, McNeill AM, Ng S, Xu Q, Vasilopoulos A, Wu S, Zhao W

Read publication

July 16, 2025

Real-world evidence shows no survival advantage with contemporary first-line strategies in papillary renal cell carcinoma: A call for randomized trials

Renal cell carcinoma

Authors: Zugman M, Rider JR, Dizman N, Castro DV, Mercier B, Shah K, Ebrahimi H, Jaime-Casas S, Barragan-Carrillo R, Sahu D, Vikramsinh Mandora P, Hsu J, Yip ...

Read publication

July 9, 2025

Developing a digital twin framework for colorectal cancer outcome prediction and robust clinical trial simulation

Colorectal cancer

Authors: Ruchlin I, Altoe M, Monberg M, Oakland T, Rossi M, Agarwal V, Chawla J, Gurha P, Yip SSF

Read publication

June 12, 2025

Characteristics of real-world NATALEE- and monarchE-eligible populations with HR+/HER2- early breast cancer: A United States electronic health records database analysis

Breast cancer

Authors: Tarantino P, Rugo HS, Curigliano G, O'Shaughnessy JA, Janni W, Jhaveri K, Mouabbi J, Brufsky A, Hamilton E, O'Regan R, Santarsiero L, Akdere M, Ye F, ...

Read publication

June 11, 2025

(PB2488) Chart review study on the real-world cytopenia management of patients with acute myeloid leukemia treated with venetoclax and hypomethylating agents

Acute Myeloid Leukemia

Authors: Zhao R, Wang Y, Dijkstra M, Wacheck V, Salimi T

Read publication

June 11, 2025

(PB2779) Chart review study on dose modifications of patients with myelodysplastic syndrome treated with hypomethylating agents

Myelodysplastic syndrome

Authors: Zhao R, Wang Y, Sano Y, Yeola S, Wachceck V, Salimi T

Read publication

May 31, 2025

Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer

Breast cancer

Authors: O'Shaughnessy J, Tolaney SM, Yardley DA, Hart L, Razavi P, Fasching PA, Janni W, Schwartzberg L, Kim J, Akdere M, McDermott C, Khakwani A, Pathak P, ...

Read publication

May 29, 2025

Comparison of outcomes for patients (pts) with R/R chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) previously treated with Bruton tyrosine kinase inhibitor (BTKi) and venetoclax from the TRANSCEND CLL 004 study versus a matched cohort of real-world (RW) pts

Chronic Lymphocytic Leukemia

Authors: Wierda WG, Wang L, Liu FF, Tuazon SA, Perna SK, Gu F, Gu T, Yue L, De Benedetti M, Fang L, Chen L, Shadman M

Read publication

May 29, 2025

Treatment patterns and survival by race among men with metastatic castration-resistant prostate cancer (mCRPC) in the United States: A US electronic medical record database 2020-2023

Prostate cancer

Authors: Raval A, Chen G, Korn M, Freedland S

Read publication

May 29, 2025

Survival impact of adjuvant chemotherapy regimens for small (T1mi/a/b), node-negative (pN0), triple-negative breast cancer (TNBC)

Breast cancer

Authors: Johnson K, Kim J, Slover B, House A, Hoeting B, Sandoval B, Thakur P, Johnson R, Roy A, Quiroga D, Bader G, Davenport A, Williams N, Cherian M, ...

Read publication

May 29, 2025

Real-world side effects of targeted therapies: High-throughput association studies leveraging the CancerLinq Discovery lung cancer database

Lung cancer

Authors: Vento J, Bastarache L, Chen Q, Osterman T

Read publication

May 29, 2025

Leveraging real-world data sources for clinical oncology research: A review of studies published in ASCO publications

N/A

Authors: Lucido T, Greenberg M, Kania B, Karam J, Bates B

Read publication

May 29, 2025

Analysis of ASCO clinical guidelines authorship and institutional representation using HemOnc.org

N/A

Authors: Jain S, Mohsin A, Herzog C, Mishra S, Cowan A, Schoen M, Yang P, Warner J

Read publication

May 29, 2025

Epidemiology of MET gene mRNA expression in metastatic colorectal cancer: Analyses of a real-world clinicogenomic database

Colorectal cancer

Authors: Calip G, Choi YC, Cai M, McNeill A, Ng S, Xu Q, Vasilopoulos A, Wu S, Zhao W

Read publication

May 29, 2025

Pediatric cancer in the United States: A comparison of three data sources

Pediatric cancers

Authors: Pace N, Huang T, Chen Q, Liu Y, Choi YC, McNeill A

Read publication

May 29, 2025

The value of integrating urology and oncology real-world data for understanding prostate cancer management

Prostate cancer

Authors: Pe Benito R, Nathasingh B, Ray H III, Chandwani S, Morgan T

Read publication

May 29, 2025

Real-world use of accelerated approval oncology drugs subsequently withdrawn in the United States

Multiple tumor types

Authors: Coutinho F, Karpes-Matusevich A, Miller V

Read publication

May 29, 2025

Comparing traditional NLP methods and LLM-based extraction for identifying biomarkers in lung cancer

Lung cancer

Authors: Joseph-Thomas J, Keswarpu P, Singh N, Jiwani K, A B, Gurha P, Tiwari S, Yadav A, Samal V, Agarwal V, Lawrence M, Martin R

Read publication

May 29, 2025

Electronic health records (EHR)-based machine learning (ML) approach to predict risk of progression to metastatic melanoma after initial diagnosis

Melanoma

Authors: Pindale R, Gemmler K, Pisano S, Tarhini A, Rider J

Read publication

May 29, 2025

Machine learning model to forecast patient availability for oncology clinical trials

N/A

Authors: Kulkarni R, Vaidya V, Parmar D, Tibrewal A, Keswarpu P, Parikh R

Read publication

May 29, 2025

Behavior of test specificity under an imperfect gold standard: Findings from a simulation study and analysis of real-world oncology data

N/A

Authors: Walker MS, Slipski L, Natanzon Y

Read publication

May 29, 2025

Real-world clinical outcomes of patients with metastatic colorectal cancer (mCRC) treated with trifluridine-tipiracil + bevacizumab by performance status

Colorectal cancer

Authors: Nusrat M, Zhao R, Penney K, Lan Z, Wang Y, Cann C, Salimi T

Read publication

May 29, 2025

Real-world patient characteristics and treatment patterns among cholangiocarcinoma patients treated with FGFR inhibitors

Cholangiocarcinoma

Authors: Mahipal A, Zhao R, Tepsick J, Lan Z, Penney K, Salimi T

Read publication

May 29, 2025

Folate receptor alpha (FRα; FOLR1) expression and persistence in ovarian cancer in clinical trial samples and real-world patient cohort

Ovarian cancer

Authors: Swisher E, Zhang Q, Mehibel M, Masica D, Lakshmikanthan S, Deutschman E, Ansell P, Coleman R

Read publication

May 26, 2025

Challenges in analyzing real-world evidence: Analysis of androgen deprivation therapy use for prostate cancer in the REASSURE study

Prostate cancer

Authors: Tran B, Yeh N, Gayle A, Holmes E, Hu J, Damineni S, Kebede N, Shore N

Read publication

May 12, 2025

Adjusted comparison of amivantamab in combination with carboplatin plus pemetrexed from the PAPILLON study versus US real-world frontline treatments in patients with advanced NSCLC harboring EGFR exon 20 insertions

Lung cancer

Authors: Schaeffer M, Lin X, Ngo N, Perualila NJ, Caparros EQ, Hales FG, Hultén A

Read publication

May 12, 2025

HSD64 Real-world adjuvant nivolumab utilization in surgically treated muscle-invasive bladder cancer patients within U.S. community oncology practice

Bladder cancer

Authors: Squires P, Coutinho F, Tepsick JG, Stuart J, Ramamurthy C, Li H, Morgan TM

Read publication

May 12, 2025

Oncology trial emulation using real-world electronic health record data: Results of the Coalition to Advance Real-World Evidence through Randomized Controlled Trial Emulation (CARE) initiative

Multiple tumor types

Authors: Levy N, Sheridan P, Campbell U, Lenis D, O'Doherty I, Estrin A, Gautam N, Zhen T, Belli A, Carrigan G, Chan A, Chen J, Chia V, Dhopeshwarkar N, ...

Read publication

May 12, 2025

Training and validation of CARAai™: A multi LLM platform and data model to address oncology-specific challenges in clinical data extraction

N/A

Authors: Rider J, Vaidya VP, Jiwani K, Elton J, Culot L, Gurha P

Read publication

May 12, 2025

Estimating US cancer prevalence with community oncology EHR-based datasets via national benchmarks from SEER and NPCR

N/A

Authors: Ray H, Li J, Chandwani S, D'Ambrosio C

Read publication

May 11, 2025

Identification of predictive subphenotypes for clinical outcomes using real world data and machine learning

Lung cancer

Authors: Pan W, Hathi D, Xu Z, Zhang Q, Li Y, Wang F

Read publication

May 7, 2025

Prognostic score models for acquired resistance to frontline anti-programmed cell death protein 1/programmed death-ligand 1 therapy in metastatic non-small-cell lung cancer

Lung cancer

Authors: Murray JC, Huang Q, Chen YC, Hu C, DiSantostefano RL, Wong C, Glatz L, Curran E, Villaruz LC, Hasan AN, Schoenfeld AJ

Read publication

May 5, 2025

Real-world clinical characteristics, treatment patterns, and clinical outcomes in US patients with stage I-III resected NSCLC without known EGFR mutations: The RESECT study

Lung cancer

Authors: Gray JE, Salomonsen RJ, Diaz Perez I, Wang A, Cai L, Wetherill G, Xiao Y, Fielden C, Georgoulia N

Read publication

May 1, 2025

Overall survival in EGFR-mutant advanced NSCLC treated with first-line osimertinib: A cohort study integrating clinical and biomarker data in the United States

Lung cancer

Authors: Sabari JK, Yu HK, Mahadevia PJ, Liu Y, Demirdjian L, Chen YH, Wang X, Passaro A

Read publication

April 30, 2025

Real-world treatment and outcomes for EGFR WT advanced/metastatic non-squamous non-small cell lung cancer: pooled analysis from project LUMINATE-101

Lung cancer

Authors: Girard N, Xu Q, Camidge DR, Baijal S, Ng S, Kamalakar R, Ratajczak C, Alhasani H, Crawford S, Karve S, Lu S

Read publication

April 24, 2025

Identifying cancer germline variants associated with patient prognosis and response by applying clinico-genomics data

Multiple tumor types

Authors: Wu S, Tsui M, McLaughlin RT, Dehal H, O'Donoghue CM, Qian J, Zhao K, Gillis BR, Rahimov F, Samayoa J, Zhao X, Zhao W

Read publication

April 24, 2025

Investigating clinical features and molecular mechanisms of long-term response and acquired resistance to immunotherapy in non-small cell lung cancer by applying real-world-data

Lung cancer

Authors: Wu S, Zhao W, Zhang B, Choi C, Akhand SS, Zhang Q, Chen J, Ansell P, Chen R, Zhao X, Samayoa J

Read publication

April 13, 2025

STREAMLINE - Retrospective cohort study of FMS-like tyrosine kinase 3-mutated acute myeloid leukemia: Real-world treatment patterns and clinical outcomes of patients in first relapse or refractory diagnosis

Acute Myeloid Leukemia

Authors: Zeidan AM, Yu R, Wang Y, Lan Z, Grinblatt DL, Elsouda D, Spalding J, Block A, Touya M, Walker MS, Pandya BJ

Read publication

March 25, 2025

Real-world treatment options for metastatic NSCLC patients following progression on chemo-immunotherapy

Lung cancer

Authors: Cortellini A, P B A, Saini KS, George R, Di Vincenzo C, Nunes P, Novikov V, Huang H, Batra U, Chico I, Ramkissoon S, Russano M, Pecci F, Tiseo M, ...

Read publication

March 19, 2025

Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2- early breast cancer

Breast cancer

Authors: Graff SL, Tolaney SM, Hart LL, Razavi P, Janni W, Schwartzberg LS, Danyliv A, Akdere M, Ferrusi I, Adhikary RR, O'Shaughnessy JA

Read publication

March 17, 2025

Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals

Multiple tumor types

Authors: Sledge GW Jr, Yoshino T, Xiu J, Helmstetter A, Ribeiro JR, Klimov S, Gilg B, Gao JJ, Elton J, Oberley MJ, Radovich M, Abraham J, Spetzler D

Read publication

March 5, 2025

Goserelin 3-month depot shows non-inferiority to the monthly formulation in U.S. patients with premenopausal breast cancer: A real-world evidence study

Breast cancer

Authors: McCann KE, Osman N, Cannon J, Brent L, Wang Y, Tepsick J, Mandora PV, Miller V, Martin N, Kaklamani VG

Read publication

February 12, 2025

Real-world treatment patterns and survival in men with metastatic castration-resistant prostate cancer (mCRPC) who previously progressed from metastatic hormone-sensitive prostate cancer (mHSPC) between 2020 to 2023 in the United States

Prostate cancer

Authors: Raval A, Chen G, Korn M, Bernthaler A, Constantinovici N, Freedland S

Read publication

February 12, 2025

Survival outcomes among metastatic castration-resistant prostate cancer patients treated with androgen receptor pathway inhibitor and docetaxel

Prostate cancer

Authors: Hwang Y , Wheeling T , Hatfield M, Kim C

Read publication

February 12, 2025

Clinical use and outcomes of androgen-receptor pathway inhibitors triplet therapy for metastatic hormone-sensitive prostate cancer (ARAAT)

Prostate cancer

Authors: McKay R, Morgans A, Khan N, Constantinovici N, Chen G, Ghadessi M, Appukkuttan S, Jhaveri J, George D

Read publication

February 12, 2025

Recurrence and its association with overall survival (OS) in muscle-invasive bladder cancer (MIBC) patients undergoing radical cystectomy (RC): A real-world analysis

Bladder cancer

Authors: Squires P , Tepsick J , Coutinho F , Rogiers A, Ramamurthy C , Li H , Morgan T

Read publication

January 31, 2025

Patients with advanced non-small cell lung cancer harboring MET alterations: A descriptive cohort study

Lung cancer

Authors: Oksen D, Boutmy E, Wang Y, Stroh C, Johne A, Nisbett AR, Ryder A

Read publication

January 30, 2025

Practice patterns and outcomes of conventional versus split-dose cisplatin in neoadjuvant ddMVAC in bladder cancer

Bladder cancer

Authors: Callihan EB, Kuna EM, Eule CJ, Kessler ER, Flaig TW

Read publication

January 22, 2025

Real-world clinical outcomes of trifluridine-tipiracil monotherapy (FTD-TPI) and FTD-TPI + bevacizumab combination therapy (FTD-TPI+bev) in 639 black patients (pts) with metastatic colorectal cancer (mCRC)

Colorectal cancer

Authors: Nusrat M, Zhao R, Khan N, Wang Y, Pierre-Victor D, Tepsick J, R S, Cann C, Salimi T

Read publication

January 22, 2025

Real-world clinical outcomes of patients (pts) with metastatic colorectal cancer (mCRC) who received trifluridine-tipiracil (FTD-TPI) monotherapy or FTD-TPI + bevacizumab (FTD-TPI+bev) combination therapy

Colorectal cancer

Authors: Nusrat M, Zhao R, Khan N, Wang Y, Pierre-Victor D, Tepsick J, R S, Cann C, Salimi T

Read publication

January 22, 2025

Biomarkers of response in patients with gastric/gastroesophageal junction adenocarcinoma (GEA) treated with telisotuzumab adizutecan

Gastric cancer/Gastroesophageal junction cancer

Authors: Strickler J, Raimbourg J, Ghiringhelli F, Cohen J, Kitagawa C, Sharma M, Lee KH, O'Neil B, Rudra-Ganguly N, Luo X, Roberts-Rapp L, Predoiu R, Zhao W, ...

Read publication

December 19, 2024

Survival outcomes of apalutamide as a starting treatment: Impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS)

Prostate cancer

Authors: Maughan BL, Liu Y, Mundle S, Wang X, Nematian-Samani M, Karsh LI

Read publication

December 18, 2024

Racial disparities in clinical trial enrollment among patients diagnosed with prostate cancer: A population-based cohort of oncology practices

Prostate cancer

Authors: Wiesen BM, Flaig TW, Gershman B, Konety B, Warren A, Kuna EM, Robin T, Kessler ER, Eule CJ, Breyer BN, Achua J, Kim SP

Read publication

December 9, 2024

Disparities in second breast cancer events and survival persist despite optimal treatment in hormone-receptor positive breast cancer: Analysis of the real-world ASCO CancerLinQ dataset

Breast cancer

Authors: Kantor O, Jones A, Mayer EL, Chavez-MacGregor M, King TA, Mittendorf EA

Read publication

December 9, 2024

Social determinants of health (SDOH) and Z code utilization among patients with breast cancer (BC)

Breast cancer

Authors: Jones N, Blair A, Lipschultz E, Koskimaki J, Smither B, Miller R

Read publication

December 9, 2024

Real-world outcomes comparing 3-monthly with monthly goserelin implant in premenopausal women with breast cancer

Breast cancer

Authors: McCann KE, Osman N, Cannon J, Brent L, Wang Y, Pierre-Victor D, Tepsick J, Mandora PV, Miller V, Martin N, Kaklamani VG

Read publication

December 6, 2024

Real-world use patterns and clinical outcomes for myelodysplastic syndrome patients initiating oral decitabine and cedazuridine or intravenous/subcutaneous hypomethylating agents

Myelodysplastic syndrome

Authors: Zeidan AM, Zhao R, Pierre-Victor D, Wang Y, Tepsick J, Lan Z, Salimi T

Read publication

December 6, 2024

Real-world treatment patterns in patients with mycosis fungoides or Sezary syndrome treated with mogamulizumab in the United States: A retrospective database analysis

Mycosis fungoides and Sezary syndrome

Authors: Haverkos BM, Chang C, Ristuccia R, Chang Y, Friderici J, Rozati S

Read publication

December 6, 2024

Mutations in the Bruton tyrosine kinase (BTK) gene in patients with chronic lymphocytic leukemia (CLL) receiving BTK inhibitors (BTKis)

Chronic Lymphocytic Leukemia

Authors: Skarbnik AP, Danilov AV, Hoffmann M, Awan FT, Scarpa F, Davies C, Oakland T, Kovach M, Lilyquist J, Munugalavadla V, Yong ASM, Shetty V, Allan JN, ...

Read publication

December 5, 2024

Real-world (RW) frontline (1L) treatments (Txs) in patients (Pts) with advanced non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EFGR) exon 20 insertions (exon20ins) and adjusted comparisons versus PAPILLON study

Lung cancer

Authors: Chouaid C, Bosquet L, Knott C, Li Z, Schaeffer M, Lin X, Schioppa C, Perualila N, Diels J, Quintero E, Galea F, Hulten A, Greystoke A

Read publication

December 3, 2024

Real-world treatment and clinical outcomes in patients with metastatic castration-resistant prostate cancer treated with olaparib in the United States

Prostate cancer

Authors: George DJ, Kariburyo-Yay F, Aggarwal H, Tepsick J, Yu R, Li W, Orji C, Ghate SR

Read publication

November 27, 2024

Evaluation of treatment strategies for patients with stage IIIA non-small cell lung cancer in the immunotherapy era

Lung cancer

Authors: Alabaster A, Velotta JB, Tupper HI, Walker MS, Natanzon Y

Read publication

November 20, 2024

Clinical characteristics and treatment of patients with small cell prostate cancer: Analysis of a real-world cohort from an oncology database

Prostate cancer

Authors: Eule CJ, Warren A, Molina Kuna E, Robin TP, Gershman B, Kim SP, Flaig TW

Read publication

November 19, 2024

Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors

Lung cancer

Authors: Naidoo J, Johnson DB, Doran C, Wang Y, Zhang Y, Le TK, Hopson S, Dreyfus B, Lal LS, Vyas C, Goldstein S, Izadi Z

Read publication

November 16, 2024

Addition of open administrative claims significantly improves capture of mortality in electronic health record (EHR) - focused real-world data (RWD)

Multiple tumor types

Authors: Slipski L, Dub B, Yu Y, Walker M, Natanzon Y

Read publication

November 15, 2024

Treatment intensification in metastatic hormone-sensitive prostate cancer: An analysis of real-world practice patterns from the CancerLinQ Database

Prostate cancer

Authors: Eule CJ, Kuna EM, Robin TP, Gershman B, Flaig TW, Kim SP

Read publication

November 9, 2024

Post-metastasis survival of patients with high-risk localized and locally advanced prostate cancer undergoing primary treatment in the United States: A retrospective study

Prostate cancer

Authors: Freedland SJ, Fernandes L, De Solda F, Buyukkaramikli N, Mundle SD, McCarthy SA, Labson D, Yang L, Pan F, Mir C

Read publication

September 30, 2024

Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Authors: Shadman M, Salkar M, Srivastava B, Karve S, Emond B, Gogna P, Manceur AM, Lafeuille MH, Rava A, Sun H, Howarth A, Tomicki S, Agatep B, Jones B, ...

Read publication

September 29, 2024

Calibrating observational health record data against a randomized trial

Lung cancer

Authors: Merola D, Campbell U, Lenis D, Schneeweiss S, Wang S, Madsen A, Carrigan G, Chia V, Ovbiosa OE, Pinheiro S, Pace N, Bruno A, Stewart M, Khosla S, ...

Read publication

September 26, 2024

Real-world clinical outcomes among patients with non-squamous advanced non-small cell lung cancer (aNSCLC) treated with docetaxel-based regimens post initial standard of care (SOC) in the United States

Lung cancer

Authors: Shah R , Kariburyo-Yay F, Apple J, Lal LS , Miller V, Reuss JE

Read publication

September 12, 2024

Characteristics of real-world (RW) NATALEE and monarchE eligible populations: A US electronic health records (EHR) database analysis

Breast cancer

Authors: Tarantino P, Rugo HS, Curigliano G, O'Shaughnessy J, Janni W, Jhaveri K, Mouabbi JA, Brufsky AM, Hamilton EP, Oregan R, Santarsiero EC, Sum E, ...

Read publication

September 12, 2024

METPRO: Evaluating prognostic value of c-Met protein overexpression and concurrent biomarker presence

Lung cancer

Authors: Le X, Aggarwal C, Simmons A, Crawford SA, Ng S, Chen C, Karve S, Stein S, Woll K, Ansell PJ, Mistry A, Bryant D, Wistuba II

Read publication

September 12, 2024

Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy

Lung cancer

Authors: Russano M, Cantini L, P B A, George R, Nunes P, Tolba K, Dutra C, Chico I, Cortellini A, Pecci F, Alessi JV, Ricciuti B, Ramkissoon S, Aerts JG, ...

Read publication

September 8, 2024

Emulations of oncology trials using real-world data: A systematic literature review

N/A

Authors: Rider JR, Wasserman A, Slipski L, Carrigan G, Harvey R, Jiao X, McRoy L, Pace ND, Becnel L, Bruno A, Eckert JC, Hodgkins P, Jain P, Merola D, Ovbiosa ...

Read publication

September 6, 2024

Real-world comparative effectiveness in advanced NSCLC and high PD-L1 with 1L immune checkpoint inhibitors ± chemotherapy

Lung cancer

Authors: Hsu ML, Xia Q, Aggarwal S, Nkhoma E, R D, Hager T, Quek R, Feliciano J

Read publication

September 6, 2024

Overall survival after treatment with first-line osimertinib for EGFR-mutant advanced NSCLC in the US

Lung cancer

Authors: Sabari JK, Yu HA, Mahadevia P, Liu Y, Demirdjian L, Sultan AA, Chen YH, Wang X, Passaro A

Read publication

September 4, 2024

Real-world treatment patterns and outcomes in patients with HR+/HER2− metastatic breast cancer treated with chemotherapy in the United States

Breast cancer

Authors: Tolaney SM, Punie K, Carey LA, Kurian AW, Ntalla I, Sjekloca N, Shah A, Rehnquist MK, Stokes M, Fraeman K, Verret W, Jhaveri K

Read publication

August 23, 2024

Immune-related adverse events of anti-PD-(L)1 immunotherapy with and without chemotherapy in patients with advanced non-small cell lung cancer: A real-world evidence study

Lung cancer

Authors: Shao P, Archambault AN, Hampp C, Sobel RE, Asubonteng J, Geba GP, Pillai AB

Read publication

August 23, 2024

Quantification of information gained by linking claims data to an EHR cohort of US metastatic breast cancer (mBC) patients

Breast cancer

Authors: Geddes J, Katz J, Asiimwe A, Brookhart MA, Carroll C, Eldemir L, Mucaj V, Nolan K, Ntalla I, Nielson CM

Read publication

August 23, 2024

Identifying the period of heightened risk for adrenal insufficiency in patients with advanced non-small cell lung cancer treated with first-line immune checkpoint inhibitors

Lung cancer

Authors: Archambault A, Breskin A, Okoye E, Ghattas M, Byrne SE, Wang J, Asubonteng J, Hampp C

Read publication

August 23, 2024

Pediatric cancer in the United States: A comparison of two data sources

Pediatric cancers

Authors: Pace ND, Huang TH, Chen Q, Liu Y, Choi YC, McNeill A

Read publication

August 23, 2024

Representativeness of race, ethnicity and social determinants of health in patients with advanced non-small cell lung cancer via linkage of real-world electronic health records, administrative claims, and consumer financial data

Lung cancer

Authors: Calip GS, Choi YC, Cai M, Liede A, Monegro N, McNeill A

Read publication

August 23, 2024

Unlocking insights: Lesson learned from the tokenization of a psoriasis trial

Psoriasis

Authors: D'Andrea E, Choi YC, Zhang D, Tepsick J, R S, Smith H, Pinheiro S, Liede A

Read publication

August 23, 2024

A combined machine learning and natural language processing approach to determine metastatic date through integrated temporal modeling

Lung cancer

Authors: Priya V, Bhattacharyya U, Chandwani S, Ray G, Tankala S, Swaminathan K, Cohen J, Vaidya V

Read publication

August 14, 2024

Evaluation of real-world tumor response derived from electronic health record data sources: A feasibility analysis in mNSCLC patients treated with chemotherapy

Lung cancer

Authors: McKelvey BA, Garrett-Mayer E, Rivera DR, Alabaster A, Andrews HS, Bond EG, Brown TD, Bruno A, Damato L, Espirito JL, Fernandes LL, Hansen E, Kluetz ...

Read publication

July 9, 2024

A retrospective analysis of treatment patterns, overall survival, and real-world disease-free survival in early-stage non-small cell lung cancer following complete resection

Lung cancer

Authors: Hu X, Chirovsky D, Walker MS, Wang Y, Kaushiva A, Tepsick J, Samkari A

Read publication

June 20, 2024

Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States

Breast cancer

Authors: Kalinsky K, Spring L, Yam C, Bhave MA, Ntalla I, Lai C, Sjekloca N, Stwalley B, Stokes M, Taylor A, Nanda R

Read publication

June 18, 2024

Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer

Breast cancer

Authors: Sukumar JS, Sardesai S, Ni A, Williams N, Johnson K, Quiroga D, Ramaswamy B, Wesolowski R, Cherian M, Stover DG, Gatti-Mays M, Pariser A, Sudheendra ...

Read publication

June 18, 2024

The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer

Breast cancer

Authors: Johnson KCC, Ni A, Quiroga D, Pariser AC, Sudheendra PK, Williams NO, Sardesai SD, Cherian M, Stover DG, Gatti-Mays M, Ramaswamy B, Lustberg M, ...

Read publication

June 2, 2024

Real-world study on the characteristics, post-nephrectomy journey, and outcomes of patients with early-stage renal cell carcinoma based on risk groups

Renal cell carcinoma

Authors: Karam JA, Bhattacharya R, Ogbomo A, Gautam S, Yu R, Sundaram M, Imai K, Chhabra J, Haas NB

Read publication

May 30, 2024

Rapid and deep prostate-specific antigen (PSA) response to apalutamide plus ADT and survival in metastatic castration-sensitive prostate cancer (mCSPC) in real world practice in the US (OASIS Project)

Prostate cancer

Authors: Maughan BL, Liu Y, Mundle S, Wang X, Karsh LI

Read publication

May 30, 2024

A real-world study on biomarker retesting among patients with non-small cell lung cancer and disparity in outcomes

Lung cancer

Authors: Crawford S, Aggarwal C, Ng S, Xu Q, Simmons A, Gulati A, Beasley MB

Read publication

May 30, 2024

Representativeness of race, ethnicity and social determinants of health in patients with advanced non-small cell lung cancer via linkage of real-world electronic health records, administrative claims, and consumer financial data

Lung cancer

Authors: Calip GS, Choi YC, Cai M, Liede A, Monegro N, McNeill A

Read publication

May 30, 2024

Predicting real-world overall survival for post-operative pancreatic ductal adenocarcinoma: An ASCO CancerLinQ Discovery analysis

Pancreatic cancer

Authors: Ahmed KS, Issaka SM, Marcinak CT, Zafar SN

Read publication

May 30, 2024

Real-world baseline treatment patterns and overall survival (rwOS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in the United States

Prostate cancer

Authors: Kariburyo-Yay F, George DJ, Aggarwal H, Tepsick JG, Yu R, Li W, Orji C, Lal LS, Ghate SR

Read publication

May 30, 2024

Dynamic machine learning model to forecast patient availability for clinical trials

Multiple myeloma

Authors: Kulkarni R, Vaidya VP, Parmar D, Tibrewal A, Parikh RB

Read publication

May 30, 2024

A prospective study comparing AI-based clinical trial eligibility screening with traditional EMR-based screening

Multiple myeloma

Authors: Joseph-Thomas J, Green C, Tibrewal A, Dupont F, Flach J, Goldstein A, Vaidya VP, Kulkarni R, Parikh RB

Read publication

May 30, 2024

Efficient site selection for clinical trials using simulated annealing

Multiple myeloma

Authors: Ruchlin I, Govil V, Samar D, Chawla J, Gurha P

Read publication

May 28, 2024

Electronic clinical quality measure (eCQM) concordance and quality care disparities among patients with breast cancer (BC)

Breast cancer

Authors: Jones N, Lipschultz E, Blair A, Smither B, Koskimaki J, Miller RS

Read publication

May 28, 2024

Disparities in patients with HER2-positive breast cancer receiving optimal treatment: Analysis of the real-world ASCO CancerLinQ dataset

Breast cancer

Authors: Kantor O, Jones AN, Mayer EL, Chavez-MacGregor M, King TA, Mittendorf EA

Read publication

May 23, 2024

Comparing prospectively assigned trial and real-world lung cancer patients

Lung cancer

Authors: Walker B, Ray HE, Shao P, D'Ambrosio C, White C, Walker MS

Read publication

May 4, 2024

An emulation of the KEYNOTE-189 trial using electronic health records

Lung cancer

Authors: Merola D, Campbell U, Lenis D, Madsen A, Schneeweiss S, Wang S, Carrigan G, Taylor A, Huang J, Chia VM, Ovbiosa O, Pinheiro S, Pace ND, Bruno A, ...

Read publication

May 4, 2024

Budget impact of pirtobrutinib for patients with mantle cell lymphoma (MCL) or chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in the United States (US)

Mantle cell lymphoma

Authors: Winfree KB, Zhang KH, Muehlenbein CE, Panjic EH, Ale-Ali A, Graham CN

Read publication

May 4, 2024

Comparative analysis of different methods of disease progression data capture in patients with metastatic castration-resistant prostate cancer

Prostate cancer

Authors: Nguyen J, Byrne C, Tang J, Patel J

Read publication

May 4, 2024

Proportional randomization method to identify index line of therapy in externally controlled trials

Mantle cell lymphoma

Authors: Cui Z, Khanal M, Chen Y, Li X, Winfree K

Read publication

May 2, 2024

Population-based trends and outcomes for cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States

Renal cell carcinoma

Authors: Wiesen B, Achua J, Warren A, Gershman B, Eule C, Kim S

Read publication

May 2, 2024

Variation in genomic testing amongst localized prostate cancer patients undergoing radical prostatectomy or radiation therapy: Results from a population-based cohort

Prostate cancer

Authors: Wiesen B, Achua J, Warren A, Konety B, Robin T, Gershman B, Flaig T, Eule C, Kim S

Read publication

April 22, 2024

EGFR mutation testing, treatment and survival in stage I–III non-small-cell lung cancer: CancerLinQ Discovery database retrospective analysis

Lung cancer

Authors: Muthusamy B, Berktas M, Li J, Thomas DS, Sun P, Taylor A, Pennell NA

Read publication

April 5, 2024

Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer

Lung cancer

Authors: Divan HA, Bittoni MA, Krishna A, Carbone DP

Read publication

April 4, 2024

Integrating real-world histopathological and clinicogenomic data from 1799 lung cancer patients by applying unsupervised deep learning

Lung cancer

Authors: Wu S, Zhao Y, Luo H, Kolahi K, Bui T, Shi X, Shrotre A, Liede A, Zhao X, Samayoa J, Zhao W

Read publication

April 4, 2024

Harness the power of real-world-data for oncology target and biomarker research: A case study by applying clinic-genomics data for 2,659 lung cancer patients and beyond

Lung cancer

Authors: Wu S, Zhao W, Choi C, Cai M, Ansell P, Liede A, Chen R, Zhao X, Samayoa J

Read publication

April 4, 2024

KRAS co-mutational landscape dictates treatment outcomes in pancreatic cancer (PC) patients

Pancreatic cancer

Authors: Ghosh P, George R, Singh N, Agrawal S

Read publication

April 4, 2024

Identifying the genetic basis for resistance to aromatase inhibitors (AIs) in metastatic breast cancer (mBC) patients

Breast cancer

Authors: Singh N, Agrawal S

Read publication

April 4, 2024

Predicting progression-free survival (PFS) in first-line (1L) immune checkpoint inhibitor (ICI)-treated patients (pts) with advanced non-small cell lung cancer (aNSCLC): Machine learning (ML) application in real-world data

Lung cancer

Authors: Hathi DK, Harnett J, Wu N, Xu Z, Pan W, Hager TG, Quek RGW, Aggarwal S, Kim Y, Rietschel P, Seebach F, Wang F, Li Y

Read publication

April 4, 2024

Identifying co-mutational signatures in STK11 mutated advanced non-small cell lung cancer (aNSCLC) patients that help overcome poor response to immune checkpoint inhibitors (ICI’s)

Lung cancer

Authors: Singh N, Agrawal S

Read publication

April 3, 2024

Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer

Lung cancer

Authors: Struebing A, McKibbon C, Ruan H, Mackay E, Dennis N, Velummailum R, He P, Tanaka Y, Xiong Y, Springford A, Rosenlund M

Read publication

March 27, 2024

Seeking American Society of Clinical Oncology-QualityOncology Practice Initiative (ASCO-QOPI) certification in anorthern New England rural health system and cancer care network

N/A

Authors: Perrey HM, Taylor E, Cropp BF, Bumpus MJ, Lessard S, Pretorius JA, Angus JH, Duperreault MF, Snow A, Wang D, Curtis M, Couture LA, Adolphson DR, ...

Read publication

February 24, 2024

Characteristics, treatment patterns, and outcomes in patients with high-risk locally advanced cervical cancer

Cervical cancer

Authors: Coutinho F, Gokhale M, Doran C, Monberg M, Yamada K, Chen L

Read publication

January 24, 2024

Patterns of concurrent chemotherapy selection in US patients undergoing trimodality therapy for muscle-invasive bladder cancer

Bladder cancer

Authors: Callihan E, Kuna EM, Robin TP, Eule CJ, Kim SP, Flaig TW

Read publication

January 24, 2024

Real world evidence comparison of first-line (1L) immune-oncology(IO)/tyrosine kinase inhibitor (TKI) vs. IO/IO combination therapy in renal cell carcinoma (RCC)

Renal cell carcinoma

Authors: Bolan P, Hui G, Low Y, Gombar S, Fan AC, Parikh DA, Shah S, Srinivas S, Khaki AR

Read publication

January 24, 2024

Survival outcomes of APA as a starting treatment: Impact in real-world patients with mCSPC (OASIS)

Prostate cancer

Authors: Maughan BL, Mundle S, Nematian-Samani M, Wang X, Du S, Liu Y, Karsh LI

Read publication

January 24, 2024

Real-world homologous recombination repair mutation (HRRm) testing patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in the United States

Prostate cancer

Authors: George DJ, Kariburyo-Yay F, Aggarwal H, Tepsick JG, Yu R, Li W, McLaurin KK, Orji C, Lal LS, Ghate SR

Read publication

January 17, 2024

Real-world treatment patterns, testing patterns, and clinical outcomes of first-line (1L) therapy for metastatic gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma (mGC/GEJC/EAC)

Gastric cancer/Gastroesophageal junction cancer

Authors: Kakehi S, Betts KA, Nie X, Kitchen SA, Ray S

Read publication

January 9, 2024

Prognosis and conditional survival among women with newly diagnosed ovarian cancer

Ovarian cancer

Authors: Szamreta EA, Monberg MJ, Desai KD, Li Y, Othus M

Read publication

December 8, 2023

Real-world progression-free survival and treatment patterns for t(11;14) positive patients with multiple myeloma with at least 2 prior lines of treatment

Multiple myeloma

Authors: Girvan A, Martins D, Yu J, Ng S, Kamalakar R, Zafar F, Tulsian S, Cornell RF, Samir M

Read publication

December 8, 2023

Real-world treatment patterns and healthcare resource utilization in patients with Waldenström macroglobulinemia initiating first-line treatment with ibrutinib or zanubrutinib

Waldenström macroglobulinemia

Authors: Paludo J, Sarosiek SR, von Keudell GR, Salkar M, Zhou S, Kim S, Cheng N, Pacia M, Karve S, Castillo JJ

Read publication

December 8, 2023

Impact of ibrutinib dose reduction on duration of therapy in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Authors: Shadman M, Karve S, Patel S, Rava A, Sun H, Howarth A, Tomicki S, Srivastava BP, Stephens DM

Read publication

December 8, 2023

Augmentation of real-world mortality data in the electronic medical record: Assessing the impact on overall survival estimates in multiple myeloma

Multiple myeloma

Authors: Liu P, Lan Z, Walker B, Ray HE, Smith H

Read publication

December 8, 2023

Real-world evaluation of outcomes in relapsed/refractory multiple myeloma patients that are triple-class exposed after receiving 2 or more prior lines of therapy

Multiple myeloma

Authors: Radwanski K, Yu J, Pierce K, Talati C, Stricker S, Jiao S, Bueno O

Read publication

December 8, 2023

Machine learning approach to understand real-world treatment in patients with higher-risk myelodysplastic syndromes

Myelodysplastic syndrome

Authors: Priya V, Vaidya VP, Agrawal S, Singh N, Chatra K, Parmar D, Yan R, Das RK, Haririfar M, McMahon P, Williamson M, Sadek I, Hogea C

Read publication

December 8, 2023

Impact of real-world treatment sequencing patterns on time to next treatment among patients with chronic lymphocytic leukemia in the United States

Chronic Lymphocytic Leukemia

Authors: Chanan-Khan AA, Challagulla S, Kaushiva A, Miller V, Wang Y, Smith H, Yang K

Read publication

December 4, 2023

Invasive disease-free survival as a surrogate for overall survival in patients with hormone receptor−positive/human epidermal growth factor receptor 2−negative early breast cancer: a real-world analysis

Breast cancer

Authors: Graff S, Tolaney S, Hart L, Razavi P, Janni W, Schwartzberg L, Danyliv A, Payan JCM, Ferrusi I, Adhikary RR, O'Shaughnessy J

Read publication

December 4, 2023

Disparities in genetic testing patterns and positivity among patients with breast cancer in the CancerLINQ real-world oncology database

Breast cancer

Authors: Kantor O, Jones A, Bychkovsky B, Laws A, Weiss A, Rana H, Garber J, Scheib R, Chavez M, Mayer E, King T, Mittendorf E

Read publication

December 2, 2023

Picturing progression: A new role of whole slide imaging in comprehensive clinical genomic datasets

Lung cancer, colorectal cancer

Authors: Sweeney EG, Wang YJ, Picard J, Abraham J, Amidi E, Rossi MR, Klimov S, D'Ambrosio C, Chen M, Elton J, Sledge G

Read publication

November 30, 2023

LUMINATE-103: Real-world treatment patterns and outcomes of patients (pts) with epidermal growth factor receptor mutant (EGFR MU), non-squamous (NSQ) locally advanced/metastatic non-small cell lung cancer (a/mNSCLC): Pooled analysis of large US electronic health record (EHR) datasets

Lung cancer

Authors: Cho BC, Xu Q, Ng S, Goldman JW, Girard N, Planchard D, Baijal S, Kamalakar R, Blot V, Alhasani H, Karve S, Lu S

Read publication

November 30, 2023

Real-world rebiopsy and biomarker retesting rates among patients with non-small cell lung cancer across patient demographics in the United States

Lung cancer

Authors: Aggarwal C, Xu Q, Ng S, Kamalakar R, Crawford S, Beruti S, Myftiu A, Beasley MB

Read publication

November 30, 2023

Real-world outcomes in patients with EGFR wildtype non-squamous locally advanced/metastatic NSCLC receiving second- or third-line docetaxel: Pooled analysis from LUMINATE-101

Lung cancer

Authors: Girard N, Xu Q, Camidge DR, Baijal S, Karve S, Ng S, Kamalakar R, Ratajczak C, Allen A, Lu S

Read publication

November 11, 2023

Risk of Death Before and After Metastasis in High-Risk Localized and Locally Advanced Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy as Primary Treatment in the United States: A Retrospective Study

Prostate cancer

Authors: Freedland S, Fernandes L, De Solda F, Buyukkaramikli N, Labson D, Yang L, Pan F, Mir MC

Read publication

November 11, 2023

A machine learning model to facilitate patient-level risk screening in myelodysplastic syndromes (MDS) patients in routine clinical practice

Myelodysplastic syndrome

Authors: Vaidya V, Vaidya V, Priya V, Parmar D, Yan R, Das R, Haririfar M, McMahon P, Williamson M, Hogea C

Read publication

November 11, 2023

Augmenting synthetic control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer

Lung cancer

Authors: Strübing A, McKibbon C, Ruan H, Mackay E, Dennis N, Velummailum R, He P, Tanaka Y, Xiong Y, Springford A, Rosenlund M

Read publication

November 1, 2023

Post-metastasis survival in high-risk localised and locally advanced prostate cancer patients undergoing primary treatment in the United States: A retrospective study

Prostate cancer

Authors: Freedland S, Fernandes L, De Solda F, Buyukkaramikli N, Mundle SD, McCarthy SA, Labson D, Yang L, Pan F, Mir C

Read publication

October 26, 2023

Uptake and efficacy of immuno-oncology combinations in metastatic renal cell carcinoma in the United States: Evidence from the ASCO CancerLinQ Discovery database

Renal cell carcinoma

Authors: Vento J, Haake SM, Beckermann K, Rini BI, Chen YW

Read publication

October 26, 2023

Implementing a BRAF biomarker electronic clinical quality measure in CancerLinQ

Colorectal cancer

Authors: Drumheller C, Barzi A, Koskimaki J

Read publication

October 26, 2023

Real-world treatment patterns and clinical outcomes post standard of care (SOC) among patients (pts) with metastatic non-small cell lung cancer (mNSCLC) with and without actionable genomic alterations (AGAs) in the United States (US)

Lung cancer

Authors: Shah R, Kariburyo-Yay F, Apple J, Lal LS, Miller V, Kwong J, Reuss JE

Read publication

October 19, 2023

Real-world (RW) use patterns, effectiveness, and tolerability of sacituzumab govitecan (SG) for second-line (2L) and later treatment of metastatic triple-negative breast cancer (mTNBC)

Breast cancer

Authors: Kalinsky K, Spring L, Yam C, Taylor A, Sjekloca N, Kaushiva A, Lai C, Ntalla I, Nanda R

Read publication

October 19, 2023

LUMINATE 102: A real-world study on biomarker testing rates among patients with non-small cell lung cancer (NSCLC) across lines of therapy

Lung cancer

Authors: Aggarwal C, Xu Q, Ng S, Kamalakar R, Crawford S, Beruti S, Myftiu A, Beasley MB

Read publication

October 17, 2023

Natural history and real-world treatment outcomes for non-small cell lung cancer patients with EGFR Exon 20 Insertion Mutation: An IASLC- ASCO CancerLinQ Study

Lung cancer

Authors: Behera M, Jiang R, Huang Z, Bunn B, Wynes MW, Switchenko J, Scagliotti GV, Belani CP, Ramalingam SS

Read publication

September 28, 2023

clinical characteristics and outcomes of Black patients with multiple myeloma compared with other races

Multiple myeloma

Authors: Spence S, Yu J, Girvan A, Ng S, Li S, Zafar F, Yellow-Duke A, Cornell RF

Read publication

September 19, 2023

Real-world pitfalls of analyzing real-world data: A cautionary note and path forward

Multiple myeloma

Authors: Cooper JD, Shou K, Sunderland K, Pham K, Thornton JA, DeStefano CB

Read publication

September 10, 2023

Improving real-world mortality data quality in oncology research: Augmenting electronic medical records with obituary, Social Security Death Index, and commercial claims data

Melanoma

Authors: Shao P, Tepsick JG, Walker B, Ray HE

Read publication

September 8, 2023

Evaluation of treatment strategies for patients with stage IIIA non-small cell lung cancer in the immunotherapy era

Lung cancer

Authors: Alabaster A, Velotta JB, Tupper HI, Natanzon Y

Read publication

September 5, 2023

Real-world analysis of a large electronic medical record database of patients with higher-risk myelodysplastic neoplasms (HR MDS): Treatment profiles, clinical effectiveness, and key adverse event rates

Myelodysplastic syndrome

Authors: Shah R, Thanataveerat A, Rudraraju R, Curtis K, Jhaveri TZ, Askin G, Irwin DE, Pierzynski J, Hogea C, Sabate EJ, Sali AP, Williamson M

Read publication

August 29, 2023

Prognostic impact of second primary malignancies in multiple myeloma: An ASCO CancerLinQ discovery analysis of the modern era

Multiple myeloma

Authors: Gibson SJ, Cooper JD, Pham K, Sunderland K, Thornton JA, DeStefano CB

Read publication

August 22, 2023

Machine learning (ML) model for prediction of pneumonitis using real-world data (RWD) on immune checkpoint inhibitor (ICI)-treated advanced non-small cell lung cancer (aNSCLC)

Lung cancer

Authors: Hall H, Mueller J, Cai MH, Liu Y, Liede A, Das R, Hathi D

Read publication

August 22, 2023

Real-world management and outcomes for newly diagnosed AML patients initiating Venetoclax and hypomethylating agents in US community practice

Acute Myeloid Leukemia

Authors: McNeill AM, Wang Y, Doran C, Cain LE, Liu Y, Lan Z, Pullarkat V

Read publication

July 27, 2023

Multiple myeloma in adolescent and young adults: An ASCO CancerLinQ and SEER analysis

Multiple myeloma

Authors: Gibson S, Thornton J , Sunderland K, Pham K, DeStefano C

Read publication

June 20, 2023

Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)

Colorectal cancer

Authors: Jin R, Ogbomo AS, Accortt NA, Lal LS, Bishi G, Sandschafer D, Goldschmidt JH

Read publication

June 12, 2023

Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2− MBC in the real world

Breast cancer

Authors: Kruse M, Smyth EN, Bowman L, Gautam S, Guimaraes CM, Nisbett AR, Fisher MD, Cui ZL, Sheffield KM, Kalinsky K

Read publication

June 8, 2023

Unfavorable early-stage Hodgkin lymphoma: assessment of patient characteristics in a real-world setting

Classical Hodgkin’s lymphoma

Authors: Gautam S, Yeola S, Nahar A, Sarpong EM, Prescott J, Yang X, Sineshaw HM

Read publication

June 7, 2023

Real-world analysis of a large electronic medical record database of patients with higher-risk myelodysplastic syndromes (HR MDS): Treatment profiles, clinical effectiveness, and key adverse events

Myelodysplastic syndrome

Authors: Shah R, Thanataveerat A, Rudraraju R, Curtis K, Jhaveri TZ, Askin G, Irwin D, Dinoso J, Hogea C, Sabate EJ, Radford M, Sali AP, Williamson M

Read publication

June 7, 2023

Real-world management and outcomes for newly diagnosed AML patients initiating Venetoclax and hypomethylating agents in US community practice

Acute Myeloid Leukemia

Authors: Wang Y, McNeill AM, Doran C, Cain LE, Liu Y, Lan Y, Cheng WH, Pullarkat V

Read publication

June 7, 2023

Patient profiles, treatment patterns, and outcomes among persistent, recurrent, or metastatic cervical cancer patients under routine care in the United States

Cervical cancer

Authors: Gokhale M, Yu R, Monberg M, Tekin C, Chen L, DeClue RW, Knapp K, Lal LS

Read publication

June 1, 2023

The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations

Lung cancer

Authors: Gray JE, Salomonsen R, Georgoulia N, Perez ID, Wang A, Cai L, Wetherill G, Xiao Y, Fielden C, Altorki NK

Read publication

June 1, 2023

Pitfalls with analyses of real-world data: A look at ASCO’s CancerLinQ Discovery multiple myeloma dataset

Multiple myeloma

Authors: Shou KJ, Thornton JA, Sunderland K, DeStefano C

Read publication

June 1, 2023

Real-world outcomes with adjuvant nonsteroidal aromatase inhibitors (NSAIs) vs tamoxifen (TAM) in patients with hormone receptor−positive/human epidermal growth factor receptor 2−negative (HR+/HER2−) early breast cancer (EBC): A US database analysis

Breast cancer

Authors: Graff SL, Tolaney SM, Hart LL, Razavi P, Fasching PA, Janni W, Schwartzberg LS, Lanoue B, Salas TR, Khakwani A, McDermott C, Pathak P, O'Shaughnessy J

Read publication

June 1, 2023

Site of metastasis (SoM) and its impact on clinical outcomes in 8 cancer cohorts

Multiple tumor types

Authors: George R, Singh N, Vidal L, Hajek E, Skalska D, Saini KS, Agrawal S

Read publication

June 1, 2023

Development of natural language processing (NLP) models for extracting key features from unstructured notes to create real-world data (RWD) assets for clinical research at scale

Lung cancer

Authors: Agrawal S, George R, Vaidya VP, Chakkrapani S, Prajapati R, Tankala S, Parmar D, Lakkimsetty VPS, Bhardwaj T, Ashwani A, Mendonca E, Narayanan B, ...

Read publication

June 1, 2023

Enhancement in line of therapy (LoT) derivation from real-world data (RWD) from electronic health records (EHR) via integration of medical claims data

N/A

Authors: Agrawal S, B AP, George R, Singh N, Soni M, Chakkrapani S, Priya V, Vaidya VP

Read publication

June 1, 2023

Racial and ethnic representation in large B-cell lymphoma trials and real-world databases

Large B-Cell Lymphoma

Authors: Munoz J, Mutebi A, Wang T, Zhang G, Yu J, He J, Chibber A, Kamalakar R, Jun MP, Adejumo K, Yang S, Kalsekar A

Read publication

June 1, 2023

Real-world clinical outcomes in patients (pts) with HR+/HER2- metastatic breast cancer (mBC) treated with chemotherapy (CT) in the United States (US)

Breast cancer

Authors: Tolaney SM, Punie K, Kurian AW, Ntalla I, Verret W, Sadetsky N, Sjekloca N, Stokes M, Jhaveri KL

Read publication

June 1, 2023

Real-world outcomes in patients (pts) with metastatic triple-negative breast cancer (mTNBC) treated with sacituzumab govitecan (SG) in 2L+ in the United States (US)

Breast cancer

Authors: Kalinsky K, Spring L, Yam C, Taylor A, Sjekloca N, Kaushiva A, Lai C, Ntalla I, Nanda R

Read publication

June 1, 2023

A real-world study of US patients with metastatic ovarian, fallopian tube, and peritoneal cancer (mOFPC) using integrated electronic health records (EHR) and claims datasets

Ovarian cancer

Authors: B AP, Funingana G, Singh N, George R, Sowa A, Chakkrapani S, Priya V, Vaidya VP, Vidal L, Saini KS, Agrawal S

Read publication

June 1, 2023

Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non–small-cell lung cancer

Lung cancer

Authors: Naidoo J, Johnson DB, Doran C, Wang Y, Zhang Y, Le TK, Hopson S, Dreyfus B, Lal LS, Vyas C, Goldstein S, Izadi Z

Read publication

June 1, 2023

Treatment patterns and outcomes among locally advanced cervical cancer patients receiving concurrent chemoradiotherapy

Cervical cancer

Authors: Coutinho F, Gokhale M, Doran C, Monberg M, Yamada KS, Chen L

Read publication

June 1, 2023

Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets

Lung cancer

Authors: McKelvey BA, Garrett-Mayer E, Belli AJ, Brown TD, Dow J, Espirito JL, Kluetz P, Ma X, McCracken A, Mishra-Kalyani PS, Natanzon Y, Potter D, Rivera D, ...

Read publication

June 1, 2023

Treatment outcomes in patients (pts) with advanced/metastatic non‑small cell lung cancer (NSCLC) harboring MET amplification as a secondary oncogenic driver

Lung cancer

Authors: Ryder A, Oksen D, Boutmy E, Ellers-Lenz B, Stroh C, Karachaliou N

Read publication

June 1, 2023

Biomarker testing and treatment patterns in US patients (pts) with advanced/metastatic non‑small cell lung cancer (NSCLC) harboring MET amplification

Lung cancer

Authors: Ryder A, Oksen D, Boutmy E, Wang Y, Nisbett AR, Stroh C, Johne A

Read publication

June 1, 2023

Evaluating clinical trial inclusion/exclusion criteria from claims using generative artificial intelligence

N/A

Authors: Mueller J, Parikh RB, Noble A

Read publication

June 1, 2023

Electronic health record (EHR) and genomics-based machine learning (ML) to predict therapeutic effectiveness among patients with hormone-receptor positive (HR)+/HER2- advanced breast cancer (aBC)

Breast cancer

Authors: Hathi DK, Pisano S, Honarvar H, Parikh RB, Das RK

Read publication

June 1, 2023

Assessment of electronic health record (EHR) –based machine learning (ML) in predicting risk of brain metastasis among patients with early-stage non–small-cell lung cancer (eNSCLC)

Lung cancer

Authors: Honarvar H, Hathi DK, Parikh RB, Das RK

Read publication

June 1, 2023

Identification of biomarkers for early progression in muscle invasive bladder cancer (MIBC) using real-world data

Bladder cancer

Authors: Singh N, George R, Agrawal S

Read publication

June 1, 2023

Digital trial solutions eScreening: software to rank patients by their predicted clinical trial eligibility using real-world data and machine learning

N/A

Authors: Bhandari S, Levonian Z, Annand R, Baxter J-Z, Cain J, Flach J, Joseph-Thomas J, Mueller J

Read publication

June 1, 2023

Electronic health record (EHR)-based machine learning (ML) to predict disease recurrence after surgical resection of early-stage non-small cell lung cancer (eNSCLC)

Lung cancer

Authors: Pisano S, Honarvar H, Parikh RB, Das RK

Read publication

May 22, 2023

Health data sharing perspectives of patients receiving care in CancerLinQ-participating oncology practices

N/A

Authors: Jagsi R, Suresh K, Krenz CD, Jones RD, Griffith KA, Perry L, Hawley ST, Zikmund-Fisher B, Spector-Bagdady K, Platt J, De Vries R, Bradbury AR, Bansal ...

Read publication

May 15, 2023

Real-world outcomes in metastatic HR+/HER2-, HER2+ and triple negative breast cancer after start of first-line therapy

Breast cancer

Authors: DeClue RW, Fisher MD, Gooden K, Walker MS, Le TK

Read publication

May 11, 2023

Comparison of advanced ovarian cancer patients treated with or without bevacizumab in the US community oncology clinics

Ovarian cancer

Authors: DeClue RW, Szamreta EA, Gautam S, Fisher MD, Monberg MJ

Read publication

May 10, 2023

Real-world treatment (Tx) patterns in patients (pts) with HR+/HER2- metastatic breast cancer (mBC) treated with chemotherapy (CT) in the United States (US)

Breast cancer

Authors: Punie K, Jhaveri , Tolaney SM, Ntalla I, Shah A, Sjekloca N, Fraeman K, Carey LA

Read publication

May 9, 2023

Clinical and economic impact of recurrence in early-stage non-small-cell lung cancer following complete resection

Lung cancer

Authors: West H, Hu X, Chirovsky D, Walker MS, Wang Y, Kaushiva A, Tepsick J, Samkari A

Read publication

May 6, 2023

Real-World Effectiveness and Treatment Patterns of Venetoclax-Based Regimens Among Patients with Chronic Lymphocytic Leukemia (CLL) Treated in Community Settings

Chronic Lymphocytic Leukemia

Authors: Zakeri M, Emechebe N, Chowdhery R, Jawaid D, Alhasani H, Manzoor BS

Read publication

May 6, 2023

Real-world study on characteristics, post-nephrectomy journey, and outcomes of patients with early-stage renal cell carcinoma based on risk groups

Renal cell carcinoma

Authors: Karam JA, Bhattacharya R, Ogbomo A, Gautam S, Yu R, Sundaram M, Imai K, Chhabra J, Haas NB

Read publication

May 6, 2023

Patient characteristics, treatment patterns, and factors of biomarker testing among patients with advanced non-small cell lung cancer (ANSCLC) in the US, 2012-2020

Lung cancer

Authors: Yang M, MacEwan J, Honnold R, McClain MR, O'Hara R, Liu F, Paik P

Read publication

April 27, 2023

Association of clinical trial enrollment and mortality amongst patients with advanced prostate cancer

Prostate cancer

Authors: Pessoa RR, Flaig T, Robin T, Gershman B, Bronsert M, Kiani K, Ballon-Landa E, Eule C, Kessler E, Smaldone MC, Kim SP

Read publication

April 27, 2023

Variation of hormonal agent usage with postoperative radiation therapy: Results from a population based cohort of prostate cancer patients in community oncology practices

Prostate cancer

Authors: Pessoa RR, Robin T, Flaig T, Molina E, Gershman B, Ballon-Landa E, Eule C, Kessler E, Chapin B, Smaldone MC, Kim SP

Read publication

April 13, 2023

Case studies for overcoming challenges in using big data in cancer

N/A

Authors: Sweeney SM, Hamadeh HK, Abrams N, Adam SJ, Brenner S, Connors DE, Davis GJ, Fiore LD, Gawel SH, Grossman RL, Hanlon SE, Hsu K, Kelloff GJ, Kirsch IR, ...

Read publication

April 13, 2023

Challenges to using big data in cancer

N/A

Authors: Sweeney SM, Hamadeh HK, Abrams N, Adam SJ, Brenner S, Connors DE, Davis GJ, Fiore L, Gawel SH, Grossman RL, Hanlon SE, Hsu K, Kelloff GJ, Kirsch IR, ...

Read publication

April 13, 2023

Machine learning (ML) on real-world data (RWD) of front-line (1L) metastatic castration resistance prostate cancer (mCRPC) patients for dynamic prediction of time to tx discontinuation (TTD)

Prostate cancer

Authors: Jain P, Hathi DK, Honarvar H, Das RK

Read publication

April 13, 2023

Machine learning (ML) model for prediction of pneumonitis using real-world data (RWD) on immune checkpoint inhibitor (ICI)-treated advanced non-small cell lung cancer (aNSCLC)

Lung cancer

Authors: Hathi DK, Hall H, Mueller J, Cai MH, Liu Y, Liede A, Das RK

Read publication

April 13, 2023

Genomic landscape of patients with non-small cell lung cancer (NSCLC)

Lung cancer

Authors: Singh NK, Saini KS, Chakkrapani S, Severson E, Nagaraj N, Ramkissoon S, Chico I, Aguilo A, George R, Vidal L, Agrawal S

Read publication

March 28, 2023

Mortality among EGFR-mutated advanced NSCLC patients after frontline osimertinib treatment: A real-world, US attrition analysis

Lung cancer

Authors: Girard N, Leighl N, Ohe Y, Kim TM, Demirdjian L, Bourla AB, Sultan AA, Mahadevia P, Bauml JM, Sabari J

Read publication

March 17, 2023

Real-world treatment patterns and outcomes of patients with metastatic nonsquamous non-small cell lung cancer after progression on standard-of-care therapy in the United States

Lung cancer

Authors: Divan HA , Bittoni MA, Krishna A, Carbone DP

Read publication

February 25, 2023

Real-world big-data: Strengths and weaknesses of ASCO's CancerLinQ® discovery multiple myeloma dataset

Multiple myeloma

Authors: DeStefano CB, Thornton JA , Gibson SJ , Pham K, Miller RS , Sunderland K

Read publication

February 21, 2023

Evaluation of cost-effectiveness of adjuvant osimertinib in patients with resected EGFR mutation-positive non-small cell lung cancer

Lung cancer

Authors: Verhoek A, Cheema P, Melosky B, Samson B, Shepherd FA, de Marinis F, John T, Wu YL, Heeg B, Van Dalfsen N, Bracke B, Miranda M, Shaw S, Moldaver D

Read publication

February 15, 2023

Comparative effectiveness of abiraterone and enzalutamide in the first-line treatment of metastatic castration-resistant prostate cancer (mCRPC): A retrospective cohort study in a large database of deeply curated EHR real-world data (RWD) from community oncology practices in the US

Prostate cancer

Authors: An H, Schoen MW, Rider J, Schorer AE, Ken J, Chen L, Alabaster A, Natanzon Y

Read publication

February 15, 2023

Real-world treatment patterns and sequencing in patients with locally advanced or metastatic urothelial cancer (la/mUC) in the US

Bladder cancer

Authors: Kearney M, Mahmoudpour H, Ike C, Modh A, Monzon S, Fragkogianni M, Carson K

Read publication

January 17, 2023

An adjusted treatment comparison comparing amivantamab versus real-world clinical practice in Europe and the United States for patients with advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations

Lung cancer

Authors: Chouaid C, Bosquet L, Girard N, Kron A, Scheffler M, Griesinger F, Sebastian M, Trigo J, Viteri S, Knott C, Rodrigues B, Rahhali N, Cabrieto J, Diels ...

Read publication

December 27, 2022

Outcomes among patients with mantle cell lymphoma post-covalent BTK inhibitor therapy in the United States: a real-world electronic medical records study

Mantle cell lymphoma

Authors: Hess LM, Chen Y, Abada PB, Konig H, Walgren RA

Read publication

December 9, 2022

Real-world treatment patterns and outcomes of daratumumab retreatment in multiple myeloma in the United States

Multiple myeloma

Authors: Girvan A, Yu J, Emechebe N, Kamalakar R, Luo Y

Read publication

December 9, 2022

Treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma receiving ≥3 lines of therapy: A real-world evaluation in the United States

Multiple myeloma

Authors: Girvan A, Yu J, Kamalakar R, Mearns ES, Nixon M, Cornell RF

Read publication

December 9, 2022

STREAMLINE - Retrospective cohort study of FLT3-mutated acute myeloid leukemia (AML): Real-world treatment patterns and clinical outcomes after first relapse or refractory (R/R) diagnosis

Acute Myeloid Leukemia

Authors: Zeidan AM, Gautam S, Yu R, Lan Z, Grinblatt DL, ElSouda D, Spalding J, Block A, Touya M, Pandya BJ

Read publication

December 9, 2022

Early-stage unfavorable Hodgkin lymphoma: Patient characteristics in real-world oncology data from the United States

Classical Hodgkin’s lymphoma

Authors: Gautam S, Yeola S, Nahar A, Sarpong EM, Prescott J, Yang X, Sineshaw HM

Read publication

December 9, 2022

Racial disparities in newly diagnosed hematological malignancies in the United States during the COVID-19 pandemic, January 2020 to March 2021

Hematological malignancies

Authors: Bhandari S, Chawla J, Jain P, Kaushiva A, Lagor C, Lal L, Mueller J, Whyte W

Read publication

December 9, 2022

Secondary primary malignancies (SPMs) in adolescent and young adults (AYAs) with multiple myeloma (MM): An ASCO CancerLinQ analysis

Multiple myeloma

Authors: Gibson SJ, Cooper JD, Thornton JA, Pham K, Sunderland K, DeStefano CB

Read publication

December 9, 2022

Survival of patients with multiple myeloma diagnosed with second primary malignancies: An ASCO CancerLinQ analysis

Multiple myeloma

Authors: Cooper JD, Thornton JA, Gibson SJ, Pham K, Sunderland K, DeStefano CB

Read publication

December 5, 2022

Real world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer

Breast cancer

Authors: Sukumar JS, Sardesai S, Ni A, Williams N, Ramaswamy B, Wesolowski R, Cherian MA, Stover D, Gatti-Mays M, Pariser AC, Sudheendra PK, George MA, ...

Read publication

November 9, 2022

Adverse events and clinical outcomes in patients treated with PD-(L)1 blockade for advanced non-small-cell lung cancer

Lung cancer

Authors: Zhang Y, Doran C, Le TK, Dreyfus B, Kola N, Sylvester BE, Lal L, Penrod JR, Meadows Shropshire S

Read publication

November 7, 2022

Effect of COVID-19 vaccination status on adverse events and outcomes in advanced non-small cell lung cancer (aNSCLC) patients treated with immunotherapies

Lung cancer

Authors: George R, Narayanan B, Agrawal S

Read publication

November 7, 2022

Identifying genetic factors for resistance and response to immune checkpoint inhibitors (ICIS) in advanced non-small cell lung cancer (aNSCLC) patients using real-world data

Lung cancer

Authors: Singh NK, Agrawal S, Narayanan B

Read publication

October 10, 2022

Real-world outcomes among HER2-positive metastatic breast cancer patients treated with trastuzumab deruxtecan in the United States

Breast cancer

Authors: Kariburyo-Yay F, Mehta S, Kwong J, Lam C, Doran C, Lan Z

Read publication

October 5, 2022

Outcomes for patients with chronic lymphocytic leukemia (CLL) previously treated with both a covalent BTK and BCL2 inhibitor in the United States: A real-world database study

Chronic Lymphocytic Leukemia

Authors: Mato AR, Hess LM, Chen Y, Abada PB, Konig H, Pagel JM, Walgren RA

Read publication

October 5, 2022

Treatment patterns and clinical outcomes among patients with relapsed/refractory classical Hodgkin's lymphoma

Classical Hodgkin’s lymphoma

Authors: Nisbett AR, Yang X, Squires P, Gautam S, Desai K, Raut M, Nahar A

Read publication

September 28, 2022

Real-world patient profiles, treatment patterns, and outcomes among recurrent, persistent, and metastatic cervical cancer patients

Cervical cancer

Authors: Gokhale M, Yu R, Monberg M, Tekin C, Fan L, DeClue R, Knapp K, Lal LS

Read publication

September 22, 2022

Lurbinectedin vs an external control arm in patients with small cell lung cancer

Lung cancer

Authors: Ganti AK, Prince P, Wang X, Estrin A, Boccuti A, Rengarajan B, Naveh N, D'Agostino Jr. R, Alvord T, Ben-Joseph R

Read publication

September 8, 2022

Unmet need in heavily pre-treated patients with HR+/HER2- metastatic breast cancer (mBC) in the US: a ConcertAI analysis

Breast cancer

Authors: Waks AG, Gharaibeh M, Sjekloca N, Poluparthi N, Shah A, Bergamaco E, MacCannell T, Leung G, Ntalla I, Oko-osi H, Tolaney SM

Read publication

September 8, 2022

Demographics, clinical characteristics, treatment patterns and clinical outcomes of patients with stages I-III resected NSCLC without known EGFR mutations

Lung cancer

Authors: Altorki NK, Salmonsen R, Georgoulia NE, Perez ID, Wang A, Cai L, Wetherill G, Xiao Y, Fielden C, Gray JE

Read publication

August 23, 2022

Use of immunosuppressive drugs and the effectiveness of immune checkpoint inhibitor therapy among patients with advanced/metastatic non-small cell lung cancer in the United States

Lung cancer

Authors: Dreyfus B, Zhang E, Doran C, Le K, Kola C, Sylvester BE, Punekar R, Lal L, Penrod J, Meadows-Shropshire SL

Read publication

August 9, 2022

Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 and Subsequent Mortality in a Multisite Cohort of Patients With Cancer in the CancerLinQ Discovery Database

Multiple tumor types

Authors: Ray EM, Riffon MF, Kakamada S, Miller RS, Potter D

Read publication

August 5, 2022

Treatment patterns and outcomes among patients with EGFR-mutant advanced NSCLC in the frontline and post-osimertinib settings

Lung cancer

Authors: Sabari J, Pisano S, Gemmler K, Mueller J, Bernabé Caro R, Girard N, Goto K, Leighl N, Ohe Y, Kim TM, Lee S-H, Demirdjian L, Rudolph S, Mahadevia P, ...

Read publication

August 5, 2022

Long term survival outcomes in NSCLC patients with targeted therapy and immunotherapy: An IASLC analysis of ASCO CancerLinQ Discovery data

Lung cancer

Authors: Behera M, Joseph G, Rupji M, Huang Z, Bunn B, Wynes M, Switchenko J, Scagliotti G, Higgins K, Tsao M, Belani C, Sequist L, Ramalingam SS

Read publication

August 3, 2022

Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients

Melanoma

Authors: Betof Warner A, Tarhini A, Kang B, Nakasato A, Ling YL, Shah R, Tang J, Patel J

Read publication

June 19, 2022

Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer

Breast cancer

Authors: Hu X, Walker MS, Stepanski E, Kaplan CM, Martin MY, Vidal GA, Schwartzberg LS, Graetz I

Read publication

June 8, 2022

Outcomes for patients with mantle cell lymphoma post-covalent BTK inhibitor therapy in the United States and Japan: a study of two real-world databases

Mantle cell lymphoma

Authors: Rai S, Hess LM, Chen Y, Bowman L, Abada PB, Konig H, Walgren RA, Tanizawa Y, Cai Z, Tajimi M

Read publication

June 4, 2022

Treatment effectiveness in a rare oncology indication: Lessons from an external control cohort study

Lung cancer

Authors: Oksen D, Prince P, Boutmy E, Garry EM, Ellers-Lenz B, Estrin A, Johne A, Verpillat P, Gatto NM

Read publication

June 2, 2022

Retrospective analysis of real-world management of EGFR-mutated advanced NSCLC, after first-line EGFR-TKI treatment: US treatment patterns, attrition, and survival data

Lung cancer

Authors: Nieva J, Reckamp KL, Potter D, Taylor A, Sun P

Read publication

June 2, 2022

Efficacy of lurbinectedin in a clinical trial versus standard of care in a real-world comparator arm in relapsed/refractory small cell lung cancer patients

Lung cancer

Authors: Ganti AK, Prince P, Wang X, Estrin A, Boccuti A, Rengarajan B, Naveh N, D'Agostino Jr. R, Alvord T, Ben-Joseph R

Read publication

June 2, 2022

Machine learning modeling of real-world primary resistance and hyperprogression in immune checkpoint inhibitor (ICI) treated advanced non-small cell lung cancer (aNSCLC) patients

Lung cancer

Authors: Das RK, Hathi DK

Read publication

June 2, 2022

Disparities in timely treatment among lung cancer patients

Lung cancer

Authors: Chhabra J, Ray H, Derkach S, Thompson D, Whyte W

Read publication

June 2, 2022

Real-world outcomes among patients with metastatic colorectal cancer treated first line with bevacizumab-awwb

Colorectal cancer

Authors: Jin R, Ogbomo AS, Accortt NA, Lal LS, Bishi G, Sandschafer D, Goldschmidt JH

Read publication

June 2, 2022

Natural language processing-optimized case selection for real-world evidence studies

Lung cancer

Authors: Koskimaki J, Hu J, Zhang Y, Mena J, Jones N, Lipschultz E, Vaidya VP, Altay G, Erese VA, Swaminathan KK, Mendonca E, Dutt T, Singh K, King T, ...

Read publication

June 2, 2022

Disease-free and overall survival outcomes for localized RCC patients by disease stage

Renal cell carcinoma

Authors: Haas NB, Bhattacharya R, Ogbomo AS, Imai K, Gautam S, Rogerio J, Yu R, Chhabra J, Sundaram M

Read publication

June 2, 2022

Identifying genetic factors of response and resistance to CDK4/6 inhibitors in metastatic HR+/HER2-breast cancer using real-world data

Breast cancer

Authors: Agrawal S, Singh N, Narayanan B

Read publication

June 2, 2022

Impact of trial site selection on minority patient recruitment in prostate cancer trials

Prostate cancer

Authors: Lagor C, Bhandari S, Chawla J, Knight M, Mann J, Mueller J, Raska P, Southwick S, Whyte W

Read publication

June 2, 2022

Evaluating the impact of performance status criteria on minority eligibility for oncology clinical trials

N/A

Authors: Bhandari S, Mann J, Chawla J, Jain P, Knight M, Lagor C, Mueller J, Raska P, Southwick S, Whyte W

Read publication

June 2, 2022

Comparison of DNA sequencing, immunohistochemistry, and in-situ hybridization techniques to determine HER2 status in metastatic breast cancer patients

Breast cancer

Authors: Lal LS, Milne D, Walker MS, Kovach M

Read publication

June 2, 2022

Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) after prior treatment (tx) with FUL in patients (pts) with advanced breast cancer (ABC): A real-world (RW) analysis

Breast cancer

Authors: O'Shaughnessy J, Woeckel A, Pistilli B, Hegg R, Vahdat LT, Vuina D, Zadeh PA, Smith TW, Kim J, Krop I

Read publication

June 2, 2022

Race differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer

Breast cancer

Authors: Hu X, Walker MS, Stepanski E, Kaplan C, Martin MY, Vidal GA, Schwartzberg LS, Graetz I

Read publication

June 2, 2022

Associations between biomarker testing and characteristics of patients with metastatic non–small cell lung cancer (mNSCLC): An analysis of CancerLinQ Discovery (CLQD) data

Lung cancer

Authors: Mileham KF, Garrett-Mayer E, Kaltenbaugh M, Kirkwood MK, Schenkel C, Bruinooge SS, Osarogiagbon RU, Jalal SI, Moore A, Roy UKB, Freeman-Daily J, ...

Read publication

June 2, 2022

Molecular testing and patterns of treatment in NSCLC patients: An IASLC analysis of ASCO CancerLinQ Discovery data

Lung cancer

Authors: Behera M, Joseph G, Rupji M, Huang Z, Bunn B, Wynes M, Switchenko JM, Scagliotti GV, Higgins KA, Tsao MS, Belani CP, Sequist LV, Ramalingam SS

Read publication

June 2, 2022

The survival benefit of anti-HER2 treatment in the management of small (T1mic, T1a, T1b, T1c), node-negative HER2+ breast cancer

Breast cancer

Authors: Johnson KCC, Ni A, Grimm M, Sardesai SD, Stover DG, Cherian MA, Gatti-Mays ME, Pariser A, Sudheendra PK, Williams NO, VanDeusen JB, Ramaswamy B, ...

Read publication

June 2, 2022

Diagnosed with advanced prostate cancer: A population-based cohort from national oncology practices

Prostate cancer

Authors: Kim SP, Kiani K, Konety B, Bronsert M, Candelario N, Kessler ER, Gershman B, Tyler R, Flaig TW

Read publication

June 2, 2022

Characterizing node-negative non-small cell lung cancer patients with similarity networks: A CancerLinQ Discovery analysis

Lung cancer

Authors: Moen EL, Chen Z, Schaefer A, Bhimani A, O'Malley J, Dragnev KH

Read publication

May 14, 2022

Cohort optimizer, a software solution that uses real-world data and AI to optimize criteria of oncology trials

N/A

Authors: Bhandari S, Mann J, Hajela R, Govil V, Greatti Y, Maguire R, Powers J, Southwick S, Mueller J

Read publication

April 30, 2022

Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies

Hematological malignancies

Authors: Thanarajasingam G, Minasian LM, Bhatnagar V, Cavalli F, De Claro RA, Dueck AC, El-Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gormley N, ...

Read publication

April 27, 2022

Cancer registry data linkage of electronic health record data from ASCO's CancerLinQ: Evaluation of advantages, limitations, and lessons learned

N/A

Authors: Charlton ME, Kahl AR, McDowell BD, Miller RS, Komatsoulis G, Koskimaki JE, Rivera DR, Cronin KA

Read publication

March 29, 2022

Disease-free survival (DFS) as a predictor of overall survival in completely reseacted early-stage non-small cell lung cancer (NSCLC)

Lung cancer

Authors: West H, Hu X, Burke T, Walker MS, Wang Y, Samkari A

Read publication

March 29, 2022

Treatment patterns, overall survival (OS), and disease-free survival (DFS) in early-stage non-small cell lung cancer (NSCLC) following complete resection

Lung cancer

Authors: West H, Hu X, Burke T, Walker MS, Wang Y, Samkari A

Read publication

March 7, 2022

Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations who progressed after platinum-based chemotherapy

Lung cancer

Authors: Minchom A, Viteri S, Bazhenova L, Gadgeel SM, Ou SHI, Trigo J, Bauml JM, Backenroth D, Bhattacharya A, Li T, Mahadevia P, Girard N

Read publication

February 21, 2022

Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ® study

Breast cancer

Authors: Miller RS, Mokiou S, Taylor A, Sun P, Baria K

Read publication

January 6, 2022

Quantitating and assessing interoperability between electronic health records

N/A

Authors: Bernstam EV, Warner JL, Krauss JC, Ambinder E, Rubinstein WS, Komatsoulis G, Miller RS, Chen JL

Read publication

January 4, 2022

Chasm between cancer quality measures and electronic health record data quality

N/A

Authors: Schorer AE, Moldwin R, Koskimaki J, Bernstam EV, Venepalli NK, Miller RS, Chen JL

Read publication

September 23, 2021

Survival in the real world: A national analysis of patients treated for early-stage breast cancer

Breast cancer

Authors: Gidwani R, Franks JA, Enogela EM, Caston NE, Williams CP, Aswani MS, Azuero A, Rocque GB

Read publication